Protagen has extended its collaboration with the National Center for Tumor Diseases, Heidelberg, to investigate the immunocompetence of urothelial cancer patients receiving immunotherapy.
Read MoreDroplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read More
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
Advanced tools and new analytical approaches promise to alter the shape of diagnostic medicine forever.
Read More
Liquid biopsy test identifies 70 of the most commonly mutated genes in solid tumors as well as microsatellite instability.
Read More